Why high-quality pre-K programs matter

Slideshow

Prekindergarten (pre-K) is a key way to prepare children for school and the benefits of a high-quality program can have long-term benefits.

Prekindergarten is a key way to prepare children for school and the benefits of a high-quality program can have long-term benefits.For more on the the importance of school readiness, check out School readiness: Why early intervention is key.

Related Videos
Perry Roy, MD | Image Credit: Carolina Attention Specialists
Angela Nash, PhD, APRN, CPNP-PC, PMHS | Image credit: UTHealth Houston
Allison Scott, DNP, CPNP-PC, IBCLC
Joanne M. Howard, MSN, MA, RN, CPNP-PC, PMHS & Anne Craig, MSN, RN, CPNP-PC
Juanita Mora, MD
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Related Content
Carissa Baker-Smith

Acknowledging obesity and hypertension in the pediatric population

May 2nd 2024
Article

A recap of the American College of Cardiology meeting and discussion of obesity and hypertension in the pediatric population.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
How healthy do parents think their children's diets are? | Image Credit: © Seventyfour- © Seventyfour - stock.adobe.com.

Parent perspectives: How are parents providing healthy diets for their children?

May 1st 2024
Article

A recent nationally representative survey revealed what types of meals parents believe are healthy for their children, and how much food is the healthy amount.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Tricuspid regurgitation velocity linked to cerebrovascular, kidney disease in SCD | Image Credit: © Rasi - © Rasi - stock.adobe.com.

Tricuspid regurgitation velocity linked to cerebrovascular, kidney disease in SCD

May 1st 2024
Article

A higher TRV was significantly associated with cerebrovascular disease and persistent albuminuria in children with SCD across two large cohorts.

BLA resubmitted for lebrikizumab to treat AD patients 12 years and up | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

BLA resubmitted for lebrikizumab to treat AD patients 12 years and up

April 30th 2024
Article

The resubmission was announced in a first quarter, 2024 earnings news release from Lilly, which expects "regulatory action in the second half of 2024."

© 2024 MJH Life Sciences

All rights reserved.